Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 11, Issue 1, 1998, Pages 19-24

  Austad, Joar ^a,f   Bjerke, Jens R ^b   Gjertsen, Bjørn T ^c   Helland, Svein ^d   Livden, John K ^e   Morken, Tore ^d   Mørk, Nils Jørgen ^a  

^a Sandvika Bad   (Norway)

^b Oslo Hudklinikk   (Norway)

^c Hudpoliklinikken Sentralsykehuset S   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e Hudpoliklinikken   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Calcipotriol; Clobetasol propionate; Psoriasis

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NORWAY; OINTMENT; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; SYMPTOMATOLOGY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CALCITRIOL; CLOBETASOL; DERMATITIS, IRRITANT; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHYSICIAN'S ROLE; PROGRAM EVALUATION; PRURITUS; PSORIASIS; PURPURA; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME;

EID: 0031858285     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(98)00008-7     Document Type: Article

References (12)

1. Lewis HM. Therapeutic progress II: treatment of psoriasis. J Clin Pharmacy Ther 1994; 19:223-232.
2. Jegasothy B, Jacobson C, Levine N, et al. Clobetasol propionate verus fluocinonide creams in psoriasis and eczema. Int J Dermatol 1985;24:461-465.
3. Jacobson C, Cornell RC, Savin RC. A comparison of clobetasol propionate 0.05% ointment and an optimized beta-methasone dipropionate 0.05% ointment in the treatment of psoriasis. Cutis 1986;37:213-220.
4. Kragballe K, Gjertsen BT, de Hoop D, et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in the treatment of psoriasis vulgaris. Lancet 1991; 337:193-195.
5. Cunliffe WJ, Berth-Jones J, Claudy A, et al. Comparative study of calcipotriol ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992;26:736-743.
6. Dubertret L, Wallach D, Souteyrand P, et al. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. J Am Acad Dermatol 1992;27:983-988.
7. Conover WJ. Practical non-parametric statistics, second ed. New York: Wiley, 1980:280-288.
8. Conover WJ. Practical non-parametric statistics, second ed. New York: Wiley, 1980:122-128.
9. Ramsay CA, Berth-Jones J, Brundin G, et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994;189:260-264.
10. Katz HI, Hein NT, Prawer SE, et al. Superpotent topical steroid treatment of psoriasis vulgaris - clinical efficacy and adrenal function. J Am Acad Dermatol 1987;16:804-811.
11. Weston WL, Fennessey PV, Morelli J, et al. Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol 1988;90:532-535.
12. Berardesca E, Vignoli G, Farinelli N, et al. Non-invasive evaluation of topical calcipotriol versus clobetasol in the treatment of psoriasis. Acta Derm Venerol (Stockholm) 1994;74:302-304.